CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
CVI.00050-08v1
15/7/1106    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Borrelli, S.
Right arrow Articles by Pinto, B. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borrelli, S.
Right arrow Articles by Pinto, B. M.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, July 2008, p. 1106-1114, Vol. 15, No. 7
1071-412X/08/$08.00+0     doi:10.1128/CVI.00050-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Immunological Evidence for Functional Rather than Structural Mimicry by a Shigella flexneri Y Polysaccharide-Mimetic Peptide{triangledown} ,{dagger}

Silvia Borrelli, Rehana B. Hossany, and B. Mario Pinto*

Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada V5A 1S6

Received 18 January 2008/ Returned for modification 25 March 2008/ Accepted 28 April 2008

An approach to vaccine design is the use of molecules that mimic the immunogenic element of interest. In this context, the interaction of MDWNMHAA, a peptide mimic of the Shigella flexneri Y O polysaccharide (PS), with an anti-carbohydrate monoclonal antibody, as studied previously by X-ray crystallography, suggested the presence of functional rather than structural mimicry and a bound peptide conformation that was not represented significantly in the free-ligand ensemble. The antibody response elicited by an MDWNMHAA-carrier protein (tetanus toxoid [TT]) conjugate has now been investigated in BALB/c mice. The mice were immunized following a homologous prime/boost strategy using MDWNMHAA-TT as the immunogen. The mice showed anti-peptide antibody (immunoglobulin G [IgG]) titers that increased after being boosted. High anti-lipopolysaccharide (LPS) (IgG) titers were observed after the last boost. A faster immune response, with cross-reactive titers, was observed with a peptide conjugate with 30% more copies of the peptide. The binding of anti-peptide polyclonal antibodies to LPS could be inhibited by LPS, PS, MDWNMHAA, and MDWNMHAA-bovine serum albumin, as assessed by inhibition enzyme-linked immunosorbent assay. Conversely, mice immunized with PS-TT showed IgG anti-peptide titers. These data demonstrate the cross-reactivity of the antibody response and support the hypothesis that functional, as opposed to structural, mimicry of the S. flexneri Y O PS by MDWNMHAA or the underrepresentation of the bound ligand conformation in the free-ligand ensemble does not compromise immunological cross-reactivity. Prime/boost strategies were performed with a heterologous boost of PS-TT or MDWNMHAA-TT. They led to high anti-LPS titers after only three injections, suggesting alternatives to improve the immunogenicity of the carbohydrate-mimetic peptide and confirming the antigenic mimicry.


* Corresponding author. Mailing address: Department of Chemistry, Simon Fraser University, Burnaby, B.C., Canada V5A 1S6. Phone: (778) 782-4152. Fax: (778) 782-4860. E-mail: bpinto{at}sfu.ca

{triangledown} Published ahead of print on 7 May 2008.

{dagger} Supplemental material for this article may be found at http://cvi.asm.org/.


Clinical and Vaccine Immunology, July 2008, p. 1106-1114, Vol. 15, No. 7
1071-412X/08/$08.00+0     doi:10.1128/CVI.00050-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.